Publications by authors named "Nancy Hardy"

Claim this Profile
C
CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphoma.
Nancy M Hardy, Jean A Yared, Tim Luetkens, Haroon Ahmad, Rediet Mulatu

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of refractory cold agglutinin syndrome using fixed-duration daratumumab, bortezomib and dexamethasone with a sutimlimab bridge.
Brad Rybinski, Miranda James, Nancy Hardy, Rima Koka, Aaron P Rapoport

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obecabtagene autoleucel, a novel CD19-directed CAR T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: the future for reducing toxicity and T-cell exhaustion?
Jean A Yared, Ariel Fromowitz, Mehmet Kocoglu, Nancy Hardy, Djordje Atanackovic

Expert Rev Hematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell Transplantation.
Gabriela Sanchez-Petitto, Olga Goloubeva, James Childress, Tahreem Iqbal, Jack Masur, Nancy M Hardy

Acta Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma.
Djordje Atanackovic, Tim Luetkens, Dina Schneider, Peirong Hu, Xu Wang, Nancy M Hardy

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell Transplant.
David T Chen, Olga Goloubeva, Aaron P Rapoport, Saurabh Dahiya, Djordje Atanackovic, Nancy Hardy

Clin Lymphoma Myeloma Leuk· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cells.
Mehmet H Kocoglu, Tim Luetkens, Jacqueline T Bork, John Baddley, Destiny Omili, Nancy M Hardy

Blood Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products.
Djordje Atanackovic, Thierry Iraguha, Destiny Omili, Stephanie V Avila, Xiaoxuan Fan, Nancy M Hardy

Cytotherapy· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells.
Yamini K Kathari, Haroon Ahmad, Michael E Kallen, Rima Koka, Destiny Omili, Nancy M Hardy

Haematologica· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.
Kathryn Kline, Tim Luetkens, Rima Koka, Michael E Kallen, Wengen Chen, Nancy M Hardy

Cancer Immunol Immunother· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by F-FDG PET/CT Imaging Following CAR-T Therapy.
Forat Lutfi, Olga Goloubeva, Amer Kowatli, Anton Gryaznov, Dong W Kim, Nancy M Hardy

Clin Lymphoma Myeloma Leuk· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD).
Kathryn Kline, Wengen Chen, Michael E Kallen, Rima Koka, Destiny Omili, Nancy M Hardy

Hum Vaccin Immunother· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review.
Aisha A Mumtaz, Andrew Fischer, Forat Lutfi, Lisa R Matsumoto, Djordje Atanackovic, Nancy M Hardy

Br J Ophthalmol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Janus kinase inhibition improve ocular graft versus host disease?
Seema Sajjan, Ellis Tibbs, Megan Utz, Aaron P Rapoport, Jean Yared, Nancy Hardy

Ocul Surf· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.
Zachary D Crees, Michael P Rettig, Reyka G Jayasinghe, Keith Stockerl-Goldstein, Sarah M Larson, Nancy Hardy

Nat Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial.
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, Brent R Logan, Farhad Khimani, Nancy M Hardy

Transplant Cell Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience.
Hanan Alkhaldi, Olga Goloubeva, Aaron P Rapoport, Saurabh Dahiya, Yifan Pang, Nancy M Hardy

Transplant Proc· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable response to ivosidenib in post-transplant relapse and leukemic transformation of myelodysplastic syndrome with new complex karyotype and R132C mutation.
Hanan Alkhaldi, Danielle Sewell, Yi Ning, Michael E Kallen, Ashkan Emadi, Nancy M Hardy

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged Lenalidomide Induction Does Not Significantly Impair Stem Cell Collection in Multiple Myeloma Patients Mobilized With Cyclophosphamide or Plerixafor: A Report From The Covid Era.
Brad Rybinski, Aaron P Rapoport, Ashraf Z Badros, Nancy Hardy, Mehmet Kocoglu

Clin Lymphoma Myeloma Leuk· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.
Djordje Atanackovic, Tim Luetkens, Destiny Omili, Thierry Iraguha, Forat Lutfi, Nancy M Hardy

Blood· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine.
Djordje Atanackovic, Robert J Kreitman, Jeffrey Cohen, Nancy M Hardy, Destiny Omili

J Immunother Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse large B-Cell lymphoma.
Dong Won Kim, Ali Bukhari, Forat Lutfi, Facundo Zafforoni, Fikru Merechi, Nancy M Hardy

Leuk Lymphoma· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine.
Kapil K Saharia, Jennifer S Husson, Silke V Niederhaus, Thierry Iraguha, Stephanie V Avila, Nancy M Hardy

Clin Transl Immunology· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy.
Saurabh Dahiya, Tim Luetkens, Forat Lutfi, Stephanie Avila, Thierry Iraguha, Nancy M Hardy

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.
Forat Lutfi, Noa G Holtzman, Ankit J Kansagra, Moaath Mustafa Ali, Ali Bukhari, Nancy M Hardy

Br J Haematol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis